Dendritic cell-based tumor vaccine adjuvant immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dendritic cell-based tumor vaccine adjuvant immunotherapy, covering 2016-05-13 to 2016-05-13. Get the full timeline:
Most recent: Clinical Trial Update: Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas) [Phase 2]